One hundred years after "carcinoid": Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

Author(s): Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, et al.

Abstract

Purpose

Neuroendocrine tumors (NETs) are considered rare tumors and can produce a variety of hormones. In this study, we examined the epidemiology of and prognostic factors for NETs, because a thorough examination of neither had previously been performed.

Methods

The Surveillance, Epidemiology, and End Results (SEER) Program registries were searched to identify NET cases from 1973 to 2004. Associated population data were used for incidence and prevalence analyses.

Similar Articles

Neuroendocrine tumours of the gallbladder: three cases and a review of the literature

Author(s): Iype S, Mirza TA, Propper DJ, Bhattacharya S, Feakins RM, et al.

Two cases of small cell carcinoma of the gallbladder

Author(s): Nau P, Liu J, Dillhoff M, Forster M, Hazey J, et al.

Combined neuroendocrine cell carcinoma and adenocarcinoma of the gallbladder: A report of a case

Author(s): Shimizu T, Tajiri T, Akimaru K, Arima Y, Yoshida H, et al.

Neuroendocrine tumor epidemiology: contrasting Norway and North America

Author(s): Hauso O, Gustafsson BI, Kidd M, Waldum HL, Drozdov I

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system

Author(s): Rindi G, Kloppel G, Alhman H, Caplin M, Couvelard A, et al.

NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors

Author(s): Clark OH, Benson AR, Berlin JD, Choti MA, Doherty GM, et al.

Gastroenteropancreatic neuroendocrine tumours

Author(s): Modlin IM, Oberg K, Chung DC, Jensen RT, De Herder WW